Liberty Dialysis - Pueblo is a medicare approved dialysis facility center in Pueblo, Colorado and it has 18 dialysis stations. It is located in Pueblo county at 850 Eagleridge Blvd, Pueblo, CO, 81008. You can reach out to the office of Liberty Dialysis - Pueblo at (719) 253-5980. This dialysis clinic is managed and/or owned by Liberty Dialysis Hawaii. Liberty Dialysis - Pueblo has the following ownership type - Profit. It was first certified by medicare in December, 2008. The medicare id for this facility is 062560 and it accepts patients under medicare ESRD program.
| Name | Liberty Dialysis - Pueblo |
|---|---|
| Location | 850 Eagleridge Blvd, Pueblo, Colorado |
| No. of Dialysis Stations | 18 |
| Medicare ID | 062560 |
| Managed By | Liberty Dialysis Hawaii |
| Ownership Type | Profit |
| Late Shifts | No |
| 850 Eagleridge Blvd, Pueblo, Colorado, 81008 | |
| (719) 253-5980 | |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| NPI Number | 1790953453 |
| Organization Name | U.s. Renal Care Pueblo Dialysis |
| Doing Business As | Liberty Dialysis Pueblo Llc |
| Address | 850 Eagle Ridge Blvd Pueblo, Colorado, 81008 |
| Phone Number | (719) 253-5980 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 67% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 13% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 72% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 14% |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 67% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 11% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 22% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 74% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 19% | 12% |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 79% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 21% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 74% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 12% |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 29 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 17 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 64 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 590 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 31 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 263 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 94 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Liberty Dialysis - Pueblo with elevated calcium levels.
| Patients with hypercalcemia | 91 |
| Hypercalcemia patient months | 863 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 93 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 39 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 43 |
| Patient months included in arterial venous fistula and catheter summaries | 350 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 79 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 63 |
| Hospitalization Rate in facility | 115.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 240.6 |
| Hospitalization Rate: Lower Confidence Limit | 57.8 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Liberty Dialysis - Pueblo were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 18.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 34.2 |
| Readmission Rate: Lower Confidence Limit | 7.9 |
News Archive
Diagnoses of autism spectrum disorder by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study publishing online April 29, 2019 in JAMA Pediatrics.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced that results from preclinical and clinical studies of two, novel blood forming agents, ACE-011 and ACE-536, will be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The European Commission has launched a project to improve health research and education in Africa by setting up excellence centres supported by advanced information and communications technologies.
› Verified 5 days ago